Works matching IS 00071048 AND DT 2024 AND VI 204 AND IP 3


Results: 53
    1

    Shades of Grey—The brain in TTP.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 757, doi. 10.1111/bjh.19293
    By:
    • Dutt, Tina;
    • Toh, Cheng‐Hock
    Publication type:
    Article
    2
    3
    4

    Sickle red blood cells directly activate neutrophils.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. e28, doi. 10.1111/bjh.19300
    By:
    • Lee, Grace M.;
    • Batchvarova, Milena;
    • Delahunty, Martha;
    • Boateng, Lydia;
    • Boyle, Kimberly;
    • Suggs, Mark A.;
    • Telen, Marilyn J.
    Publication type:
    Article
    5

    Tri‐ing to decipher trisomy AML.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 751, doi. 10.1111/bjh.19294
    By:
    • Shimony, Shai;
    • Chen, Evan C.
    Publication type:
    Article
    6
    7
    8
    9

    EPAS1‐mutated paragangliomas associated with haemoglobin disorders.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 1054, doi. 10.1111/bjh.19278
    By:
    • Mancini, Maxence;
    • Buffet, Alexandre;
    • Porte, Baptiste;
    • Amar, Laurence;
    • Lussey‐Lepoutre, Charlotte;
    • Crinière, Lise;
    • Baudin, Eric;
    • Meatchi, Tchao;
    • Gimenez‐Roqueplo, Anne‐Paule;
    • Favier, Judith;
    • Burnichon, Nelly;
    • Ajzenberg, Christiane;
    • Barraud, Sara;
    • Berthet, Pascaline;
    • Bricaire, Léopoldine;
    • Chabre, Olivier;
    • Droumaguet, Céline;
    • Fasciglione, Elsa;
    • Groussin, Lionel;
    • Guilhem, Isabelle
    Publication type:
    Article
    10

    Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based study.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 967, doi. 10.1111/bjh.19272
    By:
    • Baech, Joachim;
    • Husby, Simon;
    • Trab, Trine;
    • Kragholm, Kristian;
    • Brown, Peter;
    • Gørløv, Jette S.;
    • Jørgensen, Judit M.;
    • Gudbrandsdottir, Sif;
    • Severinsen, Marianne Tang;
    • Grønbæk, Kirsten;
    • Larsen, Thomas Stauffer;
    • Wästerlid, Tove;
    • Eloranta, Sandra;
    • Smeland, Knut B.;
    • Jakobsen, Lasse Hjort;
    • El‐Galaly, Tarec C.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    25

    Distinct karyotypic and mutational landscape in trisomy AML.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 939, doi. 10.1111/bjh.19249
    By:
    • Lam, Stephen S. Y.;
    • Tsui, Sze P.;
    • Fung, C. Y.;
    • Saw, Nicole Y.;
    • Javed, Asif;
    • Ip, Alvin H. W.;
    • Ma, Edmond S. K.;
    • Leung, Anskar Y. H.
    Publication type:
    Article
    26
    27

    Chimeric antigen receptor and bispecific T‐cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 887, doi. 10.1111/bjh.19244
    By:
    • Hammons, Lindsay;
    • Haider, Shabi;
    • Portuguese, Andrew J.;
    • Banerjee, Rahul;
    • Szabo, Aniko;
    • Pasquini, Marcelo;
    • Chhabra, Saurabh;
    • Radhakrishnan, Sabarinath;
    • Mohan, Meera;
    • Narra, Ravi;
    • Dong, Jing;
    • Janz, Siegfried;
    • Shah, Nirav N.;
    • Hamadani, Mehdi;
    • D'Souza, Anita;
    • Hari, Parameswaran;
    • Dhakal, Binod
    Publication type:
    Article
    28
    29
    30
    31

    Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 1029, doi. 10.1111/bjh.19243
    By:
    • Jonassaint, Charles R.;
    • Parchuri, Ektha;
    • O'Brien, Julia A.;
    • Lalama, Christina M.;
    • Lin, Jonathan;
    • Badawy, Sherif M.;
    • Hamm, Megan E.;
    • Stinson, Jennifer;
    • Lalloo, Chitra;
    • Carroll, C. Patrick;
    • Saraf, Santosh L.;
    • Gordeuk, Victor R.;
    • Cronin, Robert;
    • Shah, Nirmish;
    • Lanzkron, Sophie M.;
    • Liles, Darla;
    • Trimnell, Cassandra;
    • Bailey, Lakiea;
    • Lawrence, Raymona H.;
    • Abebe, Kaleab Z.
    Publication type:
    Article
    32
    33

    Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 784, doi. 10.1111/bjh.19236
    By:
    • Kulasekararaj, Austin;
    • Cavenagh, Jamie;
    • Dokal, Inderjeet;
    • Foukaneli, Theodora;
    • Gandhi, Shreyans;
    • Garg, Mamta;
    • Griffin, Morag;
    • Hillmen, Peter;
    • Ireland, Robin;
    • Killick, Sally;
    • Mansour, Sahar;
    • Mufti, Ghulam;
    • Potter, Victoria;
    • Snowden, John;
    • Stanworth, Simon;
    • Zuha, Roslin;
    • Marsh, Judith
    Publication type:
    Article
    34

    Association of ABO and Rhesus blood groups with severe outcomes from non‐SARS‐CoV‐2 respiratory infection: A prospective observational cohort study in Bristol, UK 2020–2022.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 826, doi. 10.1111/bjh.19234
    By:
    • Hathaway, Alice;
    • Qian, George;
    • King, Jade;
    • McGuinness, Serena;
    • Maskell, Nick;
    • Oliver, Jennifer;
    • Finn, Adam;
    • Danon, Leon;
    • Challen, Robert;
    • Toye, Ashley M.;
    • Hyams, Catherine;
    • Langdon, Amelia;
    • Taylor, Amy;
    • Turner, Anabella;
    • Mattocks, Anya;
    • Osborne, Bethany;
    • Grimes, Charli;
    • Mitchell, Claire;
    • Adegbite, David;
    • Bridgeman, Emma
    Publication type:
    Article
    35
    36
    37

    Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 959, doi. 10.1111/bjh.19228
    By:
    • Fuji, Shigeo;
    • Sugita, Junichi;
    • Najima, Yuho;
    • Konishi, Tatsuya;
    • Tanaka, Takashi;
    • Ohigashi, Hiroyuki;
    • Eto, Tetsuya;
    • Nagafuji, Koji;
    • Hiramoto, Nobuhiro;
    • Matsuoka, Ken‐ichi;
    • Maruyama, Yumiko;
    • Ota, Shuichi;
    • Ishikawa, Jun;
    • Kawakita, Toshiro;
    • Akasaka, Takashi;
    • Kamimura, Tomohiko;
    • Hino, Masayuki;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko;
    • Yakushijin, Kimikazu
    Publication type:
    Article
    38
    39

    A randomised evaluation of low‐dose cytosine arabinoside plus lenalidomide versus single‐agent low‐dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI‐1 trial.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 871, doi. 10.1111/bjh.19220
    By:
    • Copland, Mhairi;
    • Ariti, Cono;
    • Thomas, Ian F.;
    • Upton, Laura;
    • Sydenham, Mia;
    • Mehta, Priyanka;
    • Islam, Shahid;
    • Kjeldsen, Lars;
    • Burnett, Alan K.;
    • Hills, Robert K.;
    • Russell, Nigel;
    • Dennis, Mike
    Publication type:
    Article
    40

    Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 892, doi. 10.1111/bjh.19217
    By:
    • Castaño‐Díez, Sandra;
    • Pomares, Helena;
    • Esteban, Daniel;
    • Guijarro, Francesca;
    • Jiménez‐Vicente, Carlos;
    • Zugasti, Inés;
    • Álamo, José Ramón;
    • Mayayo, Víctor Torrecillas;
    • López‐Guerra, Mònica;
    • de la Fuente, Cristina;
    • Charry, Paola;
    • Cortés‐Bullich, Albert;
    • Bataller, Álex;
    • Maluquer, Clara;
    • Colomer, Dolors;
    • Rozman, María;
    • Arnan, Montserrat;
    • Xicoy, Blanca;
    • Esteve, Jordi;
    • Díaz‐Beyá, Marina
    Publication type:
    Article
    41

    Biallelic hypomorphic variants in CAD cause uridine‐responsive macrocytic anaemia with elevated haemoglobin‐A2.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 1067, doi. 10.1111/bjh.19215
    By:
    • Steinberg‐Shemer, Orna;
    • Yacobovich, Joanne;
    • Noy‐Lotan, Sharon;
    • Dgany, Orly;
    • Krasnov, Tanya;
    • Barg, Assaf;
    • Landau, Yuval E.;
    • Kneller, Katya;
    • Somech, Raz;
    • Gilad, Oded;
    • Brik Simon, Dafna;
    • Orenstein, Naama;
    • Izraeli, Shai;
    • del Caño‐Ochoa, Francisco;
    • Tamary, Hannah;
    • Ramón‐Maiques, Santiago
    Publication type:
    Article
    42

    R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 849, doi. 10.1111/bjh.19213
    By:
    • Watanabe, Takashi;
    • Tobinai, Kensei;
    • Wakabayashi, Masaki;
    • Maruyama, Dai;
    • Yamamoto, Kazuhito;
    • Kubota, Nobuko;
    • Shimada, Kazuyuki;
    • Asagoe, Kohsuke;
    • Yamaguchi, Motoko;
    • Ando, Kiyoshi;
    • Ogura, Michinori;
    • Kuroda, Junya;
    • Suehiro, Youko;
    • Matsuno, Yoshihiro;
    • Tsukasaki, Kunihiro;
    • Nagai, Hirokazu;
    • Fujimoto, Katsuya;
    • Ohta, Shuichi;
    • Harigae, Hideo;
    • Takahashi, Naoto
    Publication type:
    Article
    43
    44
    45
    46

    Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 839, doi. 10.1111/bjh.19201
    By:
    • AL‐Mashhadi, Ahmed Ludvigsen;
    • Jakobsen, Lasse Hjort;
    • Brown, Peter;
    • Gang, Anne Ortved;
    • Thorsteinsson, Anne‐Luise;
    • Rasoul, Kaziwa;
    • Haissman, Judith Melchior;
    • Tøstesen, Michael Buch;
    • Christoffersen, Mette Niemann;
    • Jelicic, Jelena;
    • Jørgensen, Jennifer Bøgh;
    • Thomsen, Troels;
    • Dessau‐Arp, Andriette;
    • Andersen, Andreas P. H.;
    • Frederiksen, Mikael;
    • Pedersen, Per Trøllund;
    • Clausen, Michael Roost;
    • Jørgensen, Judit Meszaros;
    • Poulsen, Christian Bjørn;
    • El‐Galaly, Tarec Christoffer
    Publication type:
    Article
    47

    Phase 1/2 study of CPX‐351 for patients with Int‐2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 3, p. 898, doi. 10.1111/bjh.19193
    By:
    • Montalban‐Bravo, Guillermo;
    • Jabbour, Elias;
    • Borthakur, Gautam;
    • Kadia, Tapan;
    • Ravandi, Farhad;
    • Chien, Kelly;
    • Pemmaraju, Naveen;
    • Hammond, Danielle;
    • Dong, Xiao Qin;
    • Huang, Xuelin;
    • Schneider, Heather;
    • John, Rosmy;
    • Kanagal‐Shamana, Rashmi;
    • Loghavi, Sanam;
    • Kantarjian, Hagop;
    • Garcia‐Manero, Guillermo
    Publication type:
    Article
    48
    49
    50